Cargando…

The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen

Detalles Bibliográficos
Autores principales: Breitner, John C. S, Martin, Barbara K, Meinert, Curtis L
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713263/
https://www.ncbi.nlm.nih.gov/pubmed/17192795
http://dx.doi.org/10.1371/journal.pctr.0010041
_version_ 1782131312814981120
author Breitner, John C. S
Martin, Barbara K
Meinert, Curtis L
author_facet Breitner, John C. S
Martin, Barbara K
Meinert, Curtis L
author_sort Breitner, John C. S
collection PubMed
description
format Text
id pubmed-1713263
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-17132632007-04-12 The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen Breitner, John C. S Martin, Barbara K Meinert, Curtis L PLoS Clin Trials Correspondence Public Library of Science 2006-12-22 /pmc/articles/PMC1713263/ /pubmed/17192795 http://dx.doi.org/10.1371/journal.pctr.0010041 Text en © 2006 Breitner et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Correspondence
Breitner, John C. S
Martin, Barbara K
Meinert, Curtis L
The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
title The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
title_full The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
title_fullStr The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
title_full_unstemmed The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
title_short The Suspension of Treatments in ADAPT: Concerns beyond the Cardiovascular Safety of Celecoxib or Naproxen
title_sort suspension of treatments in adapt: concerns beyond the cardiovascular safety of celecoxib or naproxen
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1713263/
https://www.ncbi.nlm.nih.gov/pubmed/17192795
http://dx.doi.org/10.1371/journal.pctr.0010041
work_keys_str_mv AT breitnerjohncs thesuspensionoftreatmentsinadaptconcernsbeyondthecardiovascularsafetyofcelecoxibornaproxen
AT martinbarbarak thesuspensionoftreatmentsinadaptconcernsbeyondthecardiovascularsafetyofcelecoxibornaproxen
AT meinertcurtisl thesuspensionoftreatmentsinadaptconcernsbeyondthecardiovascularsafetyofcelecoxibornaproxen
AT breitnerjohncs suspensionoftreatmentsinadaptconcernsbeyondthecardiovascularsafetyofcelecoxibornaproxen
AT martinbarbarak suspensionoftreatmentsinadaptconcernsbeyondthecardiovascularsafetyofcelecoxibornaproxen
AT meinertcurtisl suspensionoftreatmentsinadaptconcernsbeyondthecardiovascularsafetyofcelecoxibornaproxen